Know Cancer

or
forgot password


Phase 0
18 Years
35 Years
Open (Enrolling)
Female
Polycystic Ovary Syndrome

Thank you

Trial Information


Inclusion Criteria:



- Polycystic Ovary Syndrome

- Age >18 and <35

Exclusion Criteria:

- Chronic or acute inflammatory disease, cancer, autoimmune disease, treatment during
the last 6 months prior to our evaluation, DM2, hypertension, major surgery in the
last 3 months or other hormonal dysfunctions (hypothalamic, pituitary, thyroidal, or
adrenal causes).

Type of Study:

Interventional

Study Design:

Allocation: Randomized, Endpoint Classification: Efficacy Study, Intervention Model: Parallel Assignment, Masking: Double Blind (Subject, Investigator), Primary Purpose: Treatment

Outcome Measure:

CD4+ CD28 null T-lymphocyte frequency

Outcome Time Frame:

five minutes

Safety Issue:

Yes

Authority:

Italy: National Institute of Health

Study ID:

disfunzionale12

NCT ID:

NCT01574261

Start Date:

March 2012

Completion Date:

Related Keywords:

  • Polycystic Ovary Syndrome
  • Polycystic Ovary Syndrome
  • Cardiovascular risk
  • Metabolic Syndrome
  • Polycystic Ovary Syndrome

Name

Location